Schizophrenia: An epigenetic puzzle?

Schizophrenia Bulletin

Volumn 25, Issue 4, 1999, Pages 639-655

  Petronis, Arturas ^a   Paterson, Andrew D ^b   Kennedy, James L ^b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b NONE

Author keywords

Chromatin conformation; DNA methylation; Dopamine hypothesis; Epigenetics; Gene environment interaction; Genetic anticipation; Monozygotic twins; Neurodevelopment; Retroviruses; Sporadic and familial schizophrenia; Unstable DNA

Indexed keywords

DNA;

CHROMATIN STRUCTURE; DNA METHYLATION; DOPAMINERGIC SYSTEM; ENVIRONMENTAL FACTOR; HUMAN; MENTAL DISEASE; MONOZYGOTIC TWINS; PRIORITY JOURNAL; PSYCHOSIS; RETROVIRUS; REVIEW; SCHIZOPHRENIA;

EID: 0033400293     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a033408     Document Type: Review

References (180)

1. Akbarian, S.; Bunney, W.E., Jr.; Potkin, S.G.; Vinuela, A.; Kim, J.J.; and Jones, E.G. Altered distribution of nicotinamide adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenic implies disturbances of cortical development. Archives of General Psychiatry, 50:169-177, 1993.
2. Alexander, R.C.; Spector, S.A.; Casanova, M.; Kleinman, J.; Wyatt, R.J.; and Kirch, D.G. Search for cytomegalovirus in the postmortem brains of schizophrenic patients using the polymerase chain reaction. Archives of General Psychiatry, 49:47-53, 1992.
3. Allen, N.D.; Norris, M.L.; and Surani, M.A. Epigenetic control of transgene expression and imprinting by genotype-specific modifiers. Cell, 61:853-861, 1990.
4. Andreasen, N.; Nasrallah, H.A.; Dunn, V.; Olson, S.C.; Grove, W.M.; Ehrhardt, J.C.; Coffman, J.A.; and Crossett, J.H. Structural abnormalities in the frontal system in schizophrenia. A magnetic resonance imaging study. Archives of General Psychiatry, 43:136-144, 1986.
5. Arinami, T.; Gao, M.; Hamaguchi, H.; and Toru, M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Human Molecular Genetics, 6:577-582, 1997.
6. Arinami, T.; Itokawa, M.; Aoki, J.; Shibuya, H.; Ookubo, Y.; Iwawaki, A.; Ota, K.; Shimizu, H.; Hamaguchi, H.; and Toru, M. Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders. American Journal of Medical Genetics, 67:133-138, 1996.
7. Arinami, T.; Itokawa, M.; Enguchi, H.; Tagaya, H.; Yano, S.; Shimizu, H.; Hamaguchi, H.; and Toru, M. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet, 343:703-704, 1994.
8. Arnold, S.E.; Hyman, B.T.; van Hoesen, G.W.; and Damasio, A.R. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Archives of General Psychiatry, 48:625-632, 1991.
9. Ashburner, M. Drosophila: A Laboratory Handbook. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1992.
10. Asherson, P.; Williams, N.; Roberts, E.; McGuffin, M.; and Owen, M. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet, 343:1045, 1994.
11. Aylward, E.; Walker, E.; and Bittes, B. Intelligence in schizophrenia. Schizophrenia Bulletin, 10:430-459, 1984.
12. Barry, C.; Faugeron, G.; and Rossignol, J.-L. Methylation induced premeiotically in Ascobolus: Coextension with DNA repeat lengths and effect on transcript elongation. Proceedings of the National Academy of Sciences of the United States of America, 90:4557-4561, 1993.
13. Bartley, A.J.; Jones, D.W.; Torrey, E.F.; Zigun, J.R.; and Weinberger, D.R. Sylvian fissure asymmetries in monozygotic twins: A test of laterality in schizophrenia. Biological Psychiatry, 34:853-863, 1993.
14. Bednarik, D.P.; Mosca, J.D.; and Raj, N.B. Methylation as a modulator of expression of human immunodeficiency virus. Journal of Virology, 61:1253-1257, 1987.
15. Berman, K.F., and Weinberger, D.R. Functional localization in the brain in schizophrenia. In: Tasman, A., and Goldfinger, S.M., eds. American Psychiatric Press Review of Psychiatry, Vol. 10. Washington, DC: APPA Press, 1991. pp. 5-6, 136-137.
16. Bestor, T.H. DNA methyltransferase in genome defence. In: Russo, V.E.A.; Martienssen, R.A.; and Riggs, A.D., eds. Epigenetic Mechanisms of Gene Regulation. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1996. pp. 61-76.
17. Bestor, T.H.; Chandler, V.L.; and Feinberg, A.P. Epigenetic effects in eukaryotic gene expression. Developmental Genetics, 15:458-462, 1994.
18. Blum, K., and Noble, E.P. The sobering D2 story. Science, 265:1346-1347, 1994.
19. Boom, R.; Geelen, J.L.; Sol, C.J.; Minnaar, R.P.; and van der Noordaa, J. Resistance to methylation de novo of the human cytomegalovirus immediate early enhancer in a model for virus latency and reactivation in vitro. Journal of General Virology, 68:2839-2852, 1987.
20. Bowyer, S.M.; Dusheiko, G.M.; Schoub, B.D.; and Kew, M.C. Expression of the hepatitis B virus genome in chronic hepatitis B carriers and patients with hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 84:847-850, 1987.
21. Breslin, N.A., and Weinberger, D.R. Neurodevelopmental implications of findings from brain imaging studies of schizophrenia. In: Mednick, S.A.; Cannon, T.D.; Barr, C.E.; and Lyon, M., eds. Fetal Neural Development and Adult Schizophrenia. Cambridge, England: Cambridge University Press, 1991. pp. 199-215.
22. Brink, R.A. Paramutation and chromosomal organization. Quarterly Review of Biology, 35:120-137, 1960.
23. Bruton, C.J.; Crow, T.J.; Frith, C.D.; Johnstone, E.C.; Owens, D.G.C.; and Roberts, G.W. Schizophrenia and the brain: A prospective clinico-neuropathological study. Psychological Medicine, 20:285-304, 1990.
24. Chee, M.; Yang, R.; Hubbell, E.; Berno, A.; Huang, X.C.; Stern, D.; Winkler, J.; Lockhart, D.J.; Morris, M.S.; and Fodor, S.P. Accessing genetic information with high-density DNA arrays. Science, 274:610-614, 1996.
25. Chen, Y.; Chen, C.F.; Riley, D.J.; Allred, D.C.; Chen, P.L.; Von Hoff, D.; Osborne, C.K.; and Lee, W.H. Aberrant subcellular localization of BRCA1 in breast cancer. Science, 270:789-791, 1995.
26. Clark, S.J.; Harrison, J.; and Frommer, M. CpNpG methylation in mammalian cells. Nature Genetics, 10:20-27, 1995.
27. Coon, H.; Byerley, W.; Holik, J.; Hoff, M.; Myles-Worsley, M.; Lannfelt, L.; Sokoloff, P.; Schwartz, J.C.; Waldo, M.; Freedman, R.; and Plaetke, R. Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. American Journal of Human Genetics, 52:327-334, 1993.
28. Crawford, F.; Hoyne, J.; Cai, X.; Osborne, A.; Poston, D.; Zaglul, J.; Dajani, N.; Walsh, S.; Bradley, R.; Solomon, R.; and Mullan, M. Dopamine DRD2/Cys311 is not associated with chronic schizophrenia. American Journal of Medical Genetics, 67:483-484, 1996.
29. Creese, I.; Burt, D.R.; and Snyder, S.H. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science, 192:481-483, 1976.
30. Cross, A.J.; Crow, T.J.; and Owen, F. 3H-Flupenthixol binding in post-mortem brains of schizophrenics: Evidence for a selective increase in dopamine D2 receptors. Psychopharmacology (Berlin), 74:122-124, 1981.
31. Crow, T.J. A re-evaluation of viral hypothesis: Is psychosis the result of retroviral integration at a site close to the cerebral dominace gene. British Journal of Psychiatry, 145:243-253, 1984.
32. Crow, T.J. Prenatal exposure to influenza as a cause of schizophrenia. British Journal of Psychiatry, 164:588-592, 1994.
33. Crow, T.J.; Ball, J.; Bloom, S.R.; Brown, R.; Bruton, C.J.; Colter, N.; Frith, C.D.; Johnstone, E.C.; Owens, D.G.; and Roberts, G.W. Schizophrenia as an anomaly of development of cerebral asymmetry: A post-mortem study and a proposal concerning the genetic basis of the disease. Archives of General Psychiatry, 46:1145-1150, 1989.
34. Dobrovic, A., and Simpfendorfer, D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Research, 57:3347-3350, 1997.
35. Doerksen, T., and Trasler, J.M. Developmental exposure of male germ cells to 5-azacytidine results in abnormal preimplantation development in rats. Biology of Reproduction, 55:1155-1162, 1996.
36. Drinkwater, R.D.; Blake, T.J.; Morley, A.A.; and Turner, D.R. Human lymphocytes aged in vivo have reduced levels of methylation in transcriptionally active and inactive DNA. Mutation Research, 219:29-37, 1989.
37. Ehrlich, M., and Ehrlich, K.C. Effect of DNA methylation and the binding of vertebrate and plant proteins to DNA. In: Jost, J.P., and Saluz, P., eds. DNA Methylation: Molecular Biology and Biological Significance. Basel, Switzerland: Birkhauser Verlag, 1993. pp. 145-168.
38. Falkai, P.; Bogerts, B.; Greve, B.; Pfeiffer, U.; Machus, B.; Folsch-Reetz, B.; Majtenyi, C.; and Ovary, I. Loss of sylvian fissure asymmetry in schizophrenia. A quantitative post mortem study. Schizophrenia Research, 7:23-32, 1992.
39. Finnegan, E.J.; Peacock, W.J.; and Dennis, E.S. Reduced DNA methylation in Arabidopsis thaliana results in abnormal plant development. Proceedings of the National Academy of Sciences of the United States of America, 93:8449-8454, 1996.
40. Flavell, R.B. Inactivation of gene expression in plants as a consequence of novel sequence duplication. Proceedings of the National Academy of Sciences of the United States of America, 91:3490-3496, 1994.
41. Franklin, G.C.; Adam, G.I.; and Ohlsson, R. Genomic imprinting and mammalian development. Placenta, 17:3-14, 1996.
42. Frommer, M.; McDonald, L.E.; Millar, D.S.; Collis, C.M.; Watt, F.; Grigg, G.W.; Molloy, P.L.; and Paul, C.L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proceedings of the National Academy of Sciences of the United States of America, 89:1827-1831, 1992.
43. Gejman, P.V.; Ram, A.; Gelernter, J.; Friedman, E.; Cao, Q.; Pickar, D.; Blum, K.; Noble, E.P.; Kranzler, H.R.; O'Malley, S.; Dames, D.H.; Whitsitt, F.; Pao, P.; DeLisi, L.; Virkkunen, M.; Linnoila, M.; Goldman, D.; and Gershon, E.S. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia: Analysis using denaturing gradient gel electrophoresis. Journal of the American Medical Association, 271:204-208, 1994.
44. Golbus, J.; Palella, T.D.; and Richardson, B.C. Quantitative changes in T cell DNA methylation occur during differentiation and ageing. European Journal of Immunology, 20:1869-1872, 1990.
45. Goldberg, T.E.; Berman, K.F.; Moore, E.; and Weinberger, D.R. rCBF and cognition in Huntington's disease and schizophrenia: A comparison of patients matched for performance on a prefrontal-type task. Archives of Neurology, 47:418-122, 1990.
46. Gottesman, I.I. Complications to the complex inheritance of schizophrenia. Clinical Genetics, 46:116-123, 1994.
47. Gottesman, I.I.; Shields, J.; and Hanson, D.R. Schizophrenia: The Epigenetic Puzzle. Cambridge, England: Cambridge University Press, 1982.
48. Graessman, A.; Sandberg, G.; Guhl, E.; and Graessman, N. Methylation of single sites within the Herpes Simplex Virus tk coding region and the Simian virus 40T-antigen intron causes inactivation. Molecular and Cellular Biology, 14:2004-2010, 1994.
49. Green, M.F.; Satz, P.; Gaier, D.J.; Ganzell, S.; and Kharabi, F. Minor physical anomalies in schizophrenia. Schizophrenia Bulletin, 15:91-99, 1989.
50. Haaf, T.; Sirugo, G.; Kidd, K.K.; and Ward, D.C. Chromosomal localization of long trinucleotide repeats in the human genome by fluorescence in situ hybridization. Nature Genetics, 12:183-185, 1996.
51. Hayashizaki, Y.; Hirotsune, S.; Okazaki, Y.; Hatada, I.; Shibata, H.; Kawai, J.; Hirose, K.; Watanabe, S.; Fushiki, S.; Wada, S.; Sugimoto, T.; Kobayakawa, K.; Kawara, T.; Katsuki, M.; Shibuya, T.; and Mukai, T. Restriction landmark genomic scanning method and its various applications. Electrophoresis, 14:251-258, 1993.
52. Holliday, R. The inheritance of epigenetic defects. Science, 238:163-170, 1987.
53. Holliday, R. Mechanisms for the control of gene activity during development. Biological Reviews of the Cambridge Philosophical Society, 65:431-471, 1990.
54. Holliday, R. Epigenetics: An overview. Developmental Genetics, 15:453-457, 1994.
55. Holliday, R. DNA methylation in eukaryotes: 20 years on. In: Russo, V.E.A.; Martienssen, R.A.; and Riggs, A.D., eds. Epigenetic Mechanisms of Gene Regulation. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1996. pp. 5-27.
56. Holliday, R., and Pugh, J.E. DNA modification mechanisms and gene activity during development. Science, 187:226-232, 1975.
57. Hornstra, I.K.; Nelson, D.L.; Warren, S.T.; and Yang, T.P. High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Human Molecular Genetics, 2:1659-1665, 1993.
58. Jablonka, E., and Lamb, M.J. Epigenetic Inheritance and Evolution: The Lamarkian Dimension. Oxford, England: Oxford University Press, 1995.
59. Jakob, H., and Beckmann, H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. Journal of Neural Transmission, 65:303-326, 1986.
60. Jaenisch, R.; Schnieke, A.; and Harbers, K. Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues. Proceedings of the National Academy of Sciences of the United States of America, 82:1451-1455, 1985.
61. Jones, A.L.; Middle, F.; Guy, C.; Spurlock, G.; Cairns, N.J.; McGuffin, P.; Craddock, N.; Owen, M.; and O'Donovan, M.C. No evidence for expanded polyglutamine sequences in bipolar disorder and schizophrenia. Molecular Psychiatry, 2:478-482, 1997.
62. Jones, P.A. Altering DNA methylation with 5-azacytidine. Cell, 40:485-486, 1985.
63. Jorgensen, R.A. Developmental significance of epigenetic impositions on the plant genome: A paragenetic function for chromosomes. Developmental Genetics, 15:523-532, 1994.
64. Kakutani, T.; Jeddeloh, J.A.; Flowers, S.K.; Munakata, K.; and Richards, E.J. Developmental abnormalities and epimutations associated with DNA hypomethylation mutations. Proceedings of the National Academy of Sciences of the United States of America, 93:12406-12411, 1996.
65. Kalsi, G.; Mankoo, B.S.; Curtis, D.; Brynjolfsson, J.; Read, T.; Sharma, T.; Murphy, P.; Petursson, H.; and Gurling, H.M. Exclusion of linkage of schizophrenia to the gene for the dopamine D2 receptor (DRD2) and chromosome 11q translocation sites. Psychological Medicine, 25:531-537, 1995.
66. Karayiorgou, M., and Gogos, J.A. Dissecting the genetic complexity of schizophrenia. Molecular Psychiatry, 2:211-223, 1997.
67. Kawai, J.; Hirotsune, S.; Hirose, K.; Fushiki, S.; Watanabe, S.; and Hayashizaki, Y. Methylation profiles of genomic DNA of mouse developmental brain detected by restriction landmark genomic scanning (RLGS) method. Nucleic Acids Research, 21:5604-5608, 1993.
68. Kay, P.H.; Pereira, E.; Marlow, S.A.; Turbett, G.; Mitchell, C.A.; Jacobson, P.F.; Holliday, R.; and Papadimitriou, J.M. Evidence for adenine methylation within the mouse myogenic gene Myo-D1. Gene, 151:89-95, 1994.
69. Kazazian, H.H., Jr.; Wong, C.; Youssoufian, H.; Scott, A.F.; Phillips, D.G.; and Antonarakis, S.E. Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature, 332:164-166, 1988.
70. Kennedy, J.L. Molecular genetics of the dopamine receptor genes and schizophrenia. In: Niznik, H.B., ed. Dopamine Receptors and Transporters. New York, NY: Marcel Dekker Inc, 1994. pp 581-593.
71. Kirch, D.G. Infection and autoimmunity as etiologic factors in schizophrenia: A review and reappraisal. Schizophrenia Bulletin, 19:355-370, 1993.
72. Klimasauskas, S., and Roberts, R.J.M. Hhal binds tightly to substrates containing mismatches at the target base. Nucleic Acids Research, 23:1388-1395, 1995.
73. Kulynych, J.J.; Vladar, K.; Fantie, B.D.; Jones, D.W.; and Weinberger, D.R. Normal asymmetry of the planum temporale in patients with schizophrenia: Three-dimensional cortical morphometry with MRI. British Journal of Psychiatry, 166:742-749, 1995.
74. Lander, E., and Kruglyak, L. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nature Genetics, 11:241-247, 1995.
75. Leonhardt, H., and Bester, T.H. Structure, function and regulation of mammalian DNA methyltransferase. In: Jost, J.P., and Saluz, P., eds. DNA Methylation: Molecular Biology and Biological Significance. Basel, Switzerland: Birkhauser Verlag, 1993. pp. 109-119.
76. Li, E.; Bestor, T.H.; and Jaenisch, R. Target mutation of the DNA methyltransferase gene results in embryonic lethality. Cell, 69:915-926, 1992.
77. Lindblad, K.; Nylander, P.O.; De bruyn, A.; Sourey, D.; Zander, C.; Engstrom, C.; Holmgren, G.; Hudson, T.; Chotai, J.; Mendlewicz, J.; Van Broeckhoven, C.; Schalling, M.; and Adolfsson, R. Detection of expanded CAG repeats in bipolar affective disorder using the repeat expansion detection (RED) method. Neurobiology of Disease, 2:55-62, 1995.
78. Lohmann, D.R.; Gerick, M.; Brandt, B.; Oelschlager, U.; Lorenz, B.; Passarge, E.; and Horsthemke, B. Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma. American Journal of Human Genetics, 61:282-294, 1997.
79. Mandel, J.L. Human genetics. Breaking the rule of three. Nature, 386:767-769, 1997.
80. Maynard Smith, J. Models of a dual inheritance system. Journal of Theoretical Biology, 143:41-53, 1990.
81. Mays-Hoopes, L.L. Age-related changes in DNA methylation: Do they represent continued developmental changes? International Review of Cytology, 114:181-220, 1989.
82. Maziade, M.; Raymond, V.; Cliche, D.; Fournier, J.P.; Caron, C.; Garneau, Y.; Nicole, L.; Marcotte, P.; Couture, C.; Simard, C.; Boivin, R.; Rodrigue, C.; Boutin, P.; De Braekeleer, M.; Martinez, M.; and Mérette, C. Linkage results on 11Q21-22 in Eastern Quebec pedigrees densely affected by schizophrenia. American Journal of Medical Genetics, 60:522-528, 1995.
83. McGuffin, P.; Asherson, P.; Owen, M.; and Farmer, A. The strength of the genetic effect: Is there room for an environmental influence in the aetiology of schizophrenia? British Journal of Psychiatry, 164:593-599, 1994.
84. McInnis, M.G. Anticipation: An old idea in new genes. American Journal of Human Genetics, 59:973-979, 1996.
85. McNeil, T.F. Perinatal risk factors and schizophrenia: Selective review and methodological concerns. Epidemiology Reviews, 17:107-112, 1995.
86. Modrich, P. Mechanisms and biological effects of mismatch repair. Annual Review of Genetics, 25:229-253, 1991.
87. Moises, H.W.; Gelernter, J.; Giuffra, L.A.; Zarcone, V.; Wetterberg, L.; Civelli, O.; Kidd, K.K.; Cavalli-Sforza, L.L.; Grandy, D.K.; Kennedy, J.L.; Vinogradov, S.; Mauer, J.; Litt, M.; and Sjogren, B. No linkage between D2 dopamine receptor gene region and schizophrenia. Archives of General Psychiatry, 48:643-647, 1991.
88. Monk, M. Variation in epigenetic inheritance. Trends in Genetics, 6:110-114, 1990.
89. Morgan, T. H. Embryology and Genetics. New York, NY: Columbia University Press, 1934.
90. Morris, A.G.; Gaitonde, E.; McKenna, P.J.; Mollon, J.D.; and Hunt, D.M. CAG repeat expansions and schizophrenia: Association with disease in females and with early age-at-onset. Human Molecular Genetics, 4:1957-1961, 1995.
91. Morse, B.; Rotherg, P.G.; South, V.J.; Spandorfer, J.M.; and Astrin, S.M. Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature, 333:87-90, 1988.
92. Muller, P., and Seeman, P. Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors. Life Sciences, 21:1751-1758, 1977.
93. Murphy, K.C., and Owen, M.J. Minor physical anomalies and their relationship to the aetiology of schizophrenia. British Journal of Psychiatry, 168:139-142, 1996.
94. Murray, E.J., and Grosveld, F. Site specific demethylation in the promoter of human delta globin does not alleviate methylation mediated suppression. EMBO Journal, 6:2329-2335, 1987.
95. Nanko, S.; Gill, M.; Owen, M.; Takazawa, N.; Moridaira, J.; and Kazamatsuri, H. Linkage study of schizophrenia with markers on chromosome 11 in two Japanese pedigrees. Japanese Journal of Psychiatry and Neurology, 46:155-159, 1992.
96. O'Donovan, M.C.; Guy, C.; Craddock, N.; Bowen, T.; McKeon, P.; Macedo, A.; Maier, W.; Wildenauer, D.; Aschauer, H.N.; Sorbi, S.; Feldman, E.; Mynett-Johnson, L.; Claffey, E.; Nacmias, B.; Valente, J.; Dourado, A.; Grassi, E.; Lenzinger, E.; Heiden, A.M.; Moorhead, S.; Harrison, D.; Williams, J.; McGuffin, P.; and Owen, M.J. Confirmation of association between expanded CAG/CTG repeats and both schizophrenia and bipolar disorder. Psychological Medicine, 26:1145-1153, 1996.
97. O'Donovan, M.C.; Guy, C.; Craddock, N.; Murphy, K.C.; Cardno, A.G.; Jones, L.A.; Owen, M.J.; and McGuffin, P. Expanded CAG repeats in schizophrenia and bipolar disorder. Nature Genetics, 10:380-381, 1995.
98. Okano, M.; Xie, S.; and Li, E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genetics, 19:219-220, 1998.
99. O'Reilly, R.L., and Singh, S.M. Retroviruses and schizophrenia revisited. American Journal of Medical Genetics, 67:19-24, 1996.
100. Owen, F.; Cross, A.J.; Waddington, J.L.; Poulter, M.; Gamble, S.J.; and Crow, T.J. Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration. Life Sciences, 26:55-59, 1980.
101. Paterson, A.D.; Naimark, D.M.J.; Vincent, J.B.; Kennedy, J.L.; and Petronis, A. Genetic anticipation in neurological and other disorders. In: Warren, S.T., and Wells, R.D., eds. Genetic Instabilities and Hereditary Neurological Disorders. San Diego, CA: Academic Press, 1998.
102. Petronis, A. Genomic imprinting in the unstable DNA disorders. BioEssays, 18:587-590, 1996.
103. Petronis, A.; Bassett, A.S.; Honer, W.G.; Tatuch, Y.; Sasaki, T.; Ying, D.-J.; Klempan, T.A.; and Kennedy, J.L. Search for unstable DNA in schizophrenia families with evidence for genetic anticipation. American Journal of Human Genetics, 59:905-911, 1996.
104. Petronis, A., and Kennedy, J.L. Unstable genes - unstable mind? American Journal of Psychiatry, 152:164-172, 1995.
105. Petronis, A.; Kennedy, J.L.; and Paterson, A.D. Genetic anticipation: Fact or artifact, genetics or epigenetics? Lancet, 350:1403-1404, 1997.
106. Petronis, A.; Sherrington, R.P.; Paterson, A.D.; and Kennedy, J.L. Genetic anticipation in schizophrenia: Pro and con. Clinical Neuroscience, 3:76-80, 1995.
107. Razin, A., and Cedar, H. DNA methylation and embryogenesis. In: Jost, J.P., and Saluz, H.P., eds. DNA Methylation: Molecular Biology and Biological Significance. Basel, Switzerland: Birkhauser Verlag, 1993. pp. 343-356.
108. Razin, A., and Shemer, R. DNA methylation in early development. Human Molecular Genetics, 4:1751-1755, 1995.
109. Reik, W.; Hewlett, S.K.; and Surani, M.A. Imprinting by DNA methylation: From transgenes to endogenous gene sequences. Development (Suppl), 99-106, 1990.
110. Richards, E.J. DNA methylation and plant development. Trends in Genetics, 13:319-323, 1997.
111. Ridley, R.M.; Frith, C.D.; Crow, T.J.; and Conneally, P.M. Anticipation in Huntington's disease is inherited through the male line but may originate in the female. Journal of Medical Genetics, 25:589-595, 1988.
112. Riggs, A.D. X-inactivation, differentiation, and DNA methylation. Cytogenetics and Cell Genetics, 14:9-11, 1975.
113. Riggs, A.D., and Porter, T.N. Overview of genetic mechanisms. In: Russo, V.E.A.; Martienssen, R.A.; and Riggs, A.D., eds. Epigenetic Mechanisms of Gene Regulation. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1996. pp. 29-45.
114. Roberts, G.W.; Colter, N.; Lofthouse, R.; Bogerts, B.; Zech, M.; and Crow, T.J. Gliosis in schizophrenia: A survey. Biological Psychiatry, 21:1043-1050, 1986.
115. Ronemus, M.J.; Galbiati, M.; Ticknor, C.; Chen, J.; and Dellaporta, S.L. Demethylation-induced developmental pleiotropy in Arabidopsis. Science, 273:654-657, 1996.
116. Rossi, A.; Stratta, P.; Mattel, P.; Cupillari, M.; Bozzao, A.; Gallucci, M.; and Casacchia, M. Planum temporale in schizophrenia: A magnetic resonance study. Schizophrenia Research, 7:19-22, 1992.
117. Rountree, M.R., and Selker, E.U. DNA methylation inhibits elongation but not initiation of transcription in Neurospora crassa. Genes and Development, 11:2383-2395, 1997.
118. Rousseau, F.; Robb, L.J.; Rouillard, P.; and Der Kaloustian, V.M. No mental retardation in a man with 40% abnormal methylation at the FMR-I locus and transmission of sperm cell mutations as premutations. Human Molecular Genetics, 3:927-930, 1994.
119. Rubinsztein, D.C.; Leggo, J.; Coles, R.; Almqvist, E.; Biancalana, V.; Cassiman, J.J.; Chotai, K.; Connarty, M.; Crauford, D.; Curtis, A.; Curtis, D.; Davidson, M.J.; Differ, A.M.; Dode, C.; Dodge, A.; Frontali, M.; Ranen, N.G.; Stine, O.C.; Sherr, M.; Abbott, M.H.; Franz, M.L.; Graham, C.A.; Harper, P.S.; Hedreen, J.C.; Jackson, A.; Kaplan, J.-C.; Losekoot, M.; MacMillan, J.C.; Morrison, P.; Trottier, Y.; Novelletto, A.; Simpson, S.A.; Theilmann, J.; Whittaker, J.L.; Folstein, S.E.; Ross, C.A.; and Hayden, M.R. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. American Journal of Human Genetics, 59:16-22, 1996.
120. Saluz, H., and Jost, J.P. Major techniques to study DNA methylation. In: Jost, J.P., and Saluz, H.P., eds. DNA Methylation: Molecular Biology and Biological Significance, Basel, Switzerland: Birkhauser Verlag, 1993. pp. 11-26.
121. Sandmeyer, S.B.; Hansen, L.J.; and Chalker, D.L. Integration specificity of retrotransposons and retroviruses. Annual Review of Genetics, 24:491-518, 1990.
122. Sapienza, C.; Paquette, J.; Tran, T.H.; and Peterson, A. Epigenetic and genetic factors affect transgene methylation imprinting. Development, 107:165-168, 1989.
123. Sarkar, G.; Kapelner, S.; Grandy, D.K.; Marchionni, M.; Civelli, O.; Sobell, J.; Heston, L.; and Sommer, S.S. Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics, 11:8-14, 1991.
124. Sasaki, T.; Macciardi, F.M.; Badri, F.; Verga, M.; Meltzer, H.Y.; Lieberman, J.; Howard, A.; Bean, G.; Joffe, R.T.; Hudson, C.J.; and Kennedy, J.L. No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis. American Journal of Medical Genetics, 67:415-417, 1996.
125. Seeman, P. Dopamine receptor sequences: Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology, 7:261-284, 1992.
126. Seeman, P.; Bzowej, N.H.; Guan, H.C.; Bergeron, C.; Reynolds, G.P.; Bird, E.D.; Riederer, P.; Jellinger, K.; and Tourtellotte, W.W. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology, 1:5-15, 1987.
127. 3H]benzquinoline. Synapse, 25:137-146, 1997.
128. Seeman, P.; Lee, T.; Chau-Wong, M.; and Wong, K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature, 261:717-719, 1976.
129. Seeman, P., and Niznik, H.B. Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB Journal, 4:2737-2744, 1990.
130. Seeman, P.; Ohara, K.; Ulpian, C.; Seeman, M.V.; Jellinger, K.; Van Tol, H.H.; and Niznik, H.B. Schizophrenia: Normal sequence in the dopamine D2 receptor region that couples to G-proteins. DNA polymorphisms in D2. Neuropsychopharmacology, 8:137-142, 1993.
131. Seeman, P.; Ulpian, C.; Bergeron, C.; Riederer, P.; Jellinger, K.; Gabriel, E.; Reynolds, G.P.; and Tourtellotte, W. W. Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science, 225:728-731, 1984.
132. Shaikh, S.; Collier, D.; Arranz, M.; Ball, D.; Gill, M.; and Kerwin, R. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet, 343:1045-1046, 1994.
133. Shemer, R., and Razin, A. Establishment of imprinted methylation patterns during development. In: Russo, V.E.A.; Martienssen, R.A.; and Riggs, A.D., eds. Epigenetic Mechanisms of Gene Regulation. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1996. pp. 215-229.
134. Shpaer, E.G., and Mullins, J.I. Selection against CpG dinucleotides in lentiviral genes: A possible role of methylation in regulation of viral expression. Nucleic Acids Research, 18:5793-5797, 1990.
135. Sidransky, E.; Burgess, C.; Ikeuchi, T.; Lindblad, K.; Long, R.T.; Philibert, R.A.; Rapoport, J.; Schalling, M.; Tsuji, S.; and Ginns, E.I. A triplet repeat on 17q accounts for most expansions detected by the repeat-expansion-detection technique. American Journal of Human Genetics, 62:1548-1551, 1998.
136. Sierra-Honigmann, A.M.; Carbone, K.M.; and Yolken, R.H. Polymerase chain reaction (PCR) search for viral nucleic acid sequences in schizophrenia. British Journal of Psychiatry, 166:55-60, 1995.
137. Singhal, R.P.; Mays-Hoopes, L.L.; and Eichhorn, G.L. DNA methylation in aging of mice. Mechanisms of Ageing and Development, 41:199-210, 1987.
138. Sirugo, G.; Pakstis, A.J.; Kidd, K.K.; Matthysse, S.; Levy, D.L.; Holzman, P.S.; Parnas, J.; McInnis, M.; Breschel, T.; and Ross, C.A. Detection of a large CTG/CAG trinucleotide repeat expansion in a Danish schizophrenia kindred. American Journal of Medical Genetics, 74:546-548, 1997.
139. Smith, P.R., and Griffin, B.E. Differential expression of Epstein Barr viral transcripts for two proteins (TP1 and LMP) in lymphocyte and epithelial cells. Nucleic Acids Research, 19:2435-2440, 1991.
140. Spangler, C.M., and Essani, K. Transactivation of methylated HIV-LTR by a frog virus 3 protein. Virology, 204:651-655, 1994.
141. Spurlock, G.; Williams, J.; McGuffin, P.; Aschauer, H.N.; Lenzinger, E.; Fuchs, K.; Sieghart, W.C.; Meszaros, K.; Fathi, N.; Laurent, C.; Mallet, J.; Macciardi, F.; Pedrini, S.; Gill, M.; Hawi, Z.; Gibson, S.; Jazin, E.E.; Yang, H.T.; Adolfsson, R.; Pato, C.N.; Dourado, A.M.; and Owen, M.J. European Multicentre Association study of schizophrenia: A study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. American Journal of Medical Genetics, 81:24-28, 1998.
142. Srivastava, L.K.; Morency, M.A.; and Mishra, R.K. Ontogeny of dopamine D2 receptor mRNA in rat brain. European Journal of Pharmacology, 225:143-150, 1992.
143. Stober, G.; Jatzke, S.; Heils, A.; Jungkunz, G.; Knapp, M.; Mossner, R.; Riederer, P.; and Lesch, K.P. Insertion/deletion variant (-141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: Lack of association with schizophrenia and bipolar affective disorder. Short communication. Journal of Neural Transmission, 105:101-109, 1998.
144. Sully, R.; Ganesan, S.; Brown, M.; De Caprio, J.A.; Cannistra, S.A.; Feunteun, J.; Schnitt, S.; and Livingston, D.M. Location of BRCA1 in human breast and ovarian cancer cells. Science, 272:123-126, 1996.
145. Susser, E.; Neugebauer, R.; Hoek, H.W.; Brown, A.S.; Lin, S.; Labovitz, D.; and Gorman, J.M. Schizophrenia after prenatal famine. Further evidence. Archives of General Psychiatry, 53:25-31, 1996.
146. Taller, A.M.; Asher, D.M.; Pomeroy, K.L.; Eldadah, B.A.; Godec, M.S.; Falkai, P.G.; Bogert, B.; Kleinman, J.E.; Stevens, J.R.; and Torrey, E.F. Search for viral nucleic acid sequences in brain tissues of patients with schizophrenia using nested polymerase chain reaction. Archives of General Psychiatry, 53:32-40, 1996.
147. Taneja, K.L.; McCurrach, M.; Schalling, M.; Housman, D.; and Singer, R.H. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. Journal of Cell Biology, 128:995-1002, 1995.
148. Tasseron-de Jong, J.; Aker, J.; Der Dulk, H.; van de Putte, P.; and Giphart-Gassler, M. Cytosine methylation in the co site of active and inactive herpes virus thymidine kinase promoters. Biochimica et Biophysica Acta, 1008:62-70, 1989.
149. Tawa, R.; Ono, T.; Kurishita, A.; Okada, S.; and Hirose, S. Changes of DNA methylation level during pre-and post-natal periods in mice. Differentiation, 45:44-48, 1990.
150. Tollefsbol, T.O., and Hutchinson, C.A. III. Control of methylation spreading in synthetic DNA sequences by the murine DNA methyltransferase. Journal of Molecular Biology, 269:494-504, 1997.
151. Torrey, E.F. Are we overestimating the genetic contribution to schizophrenia? Schizophrenia Bulletin, 18:159-170, 1992.
152. Tsujita, T.; Niikawa, N.; Yamashita, H.; Imamura, A.; Hamada, A.; Nakane, Y.; and Okazaki, Y. Genomic discordance between monozygotic twins discordant for schizophrenia. American Journal of Psychiatry, 155:422-424, 1998.
153. Uehara, Y.; Ono, T.; Kurishita, A.; Kokuryu, H.; and Okada, S. Age-dependent and tissue-specific changes of DNA methylation within and around the c-fos gene in mice. Oncogene, 4:1023-1028, 1989.
154. Ushijima, T.; Morimura, K.; Hosoya, Y.; Okonogi, H.; Tatematsu, M.; Sugimura, T.; and Nagao, M. Establishment of methylation-sensitive-representational difference analysis and isolation of hypo-and hypermethylated genomic fragments in mouse liver tumors. Proceedings of the National Academy of Sciences of the United States of America, 94:2284-2289, 1997.
155. Van Tol, H.H.; Bunzow, J.R.; Guan, H.C.; Sunahara, R.K.; Seeman, P.; Niznik, H.B.; and Civelli, O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature, 350:610-614, 1991.
156. Verdoux, H.; Geddes, J.R.; Takei, N.; Lawrie, S.M.; Bovet, P.; Eagles, J.M.; Heun, R.; McCreadie, R.G.; McNeil, T.F.; O'Callaghan, E.; Stober, G.; Willinger, M.U.; Wright, P.; and Murray, R.M. Obstetric complications and age at onset in schizophrenia: An international collaborative meta-analysis of individual patient data. American Journal of Psychiatry, 154:1220-1227, 1997.
157. Verga, M.; Macciardi, F.; Pedrini, S.; Cohen, S.; and Smeraldi, E. No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk. Schizophrenia Research, 25:117-121, 1997.
158. Vicente, A.M., and Kennedy, J.L. The genetics of neurodevelopment and schizophrenia. In: Keshavan, M.S., and Murray, R.M., eds. Neurodevelopmental Origins of Psychopathology. Cambridge, England: Cambridge University Press, 1997. pp. 31-55.
159. Vieland, V.J., and Huang, J. Statistical evaluation of age-at-onset anticipation: A new test and evaluation of its behavior in realistic applications. American Journal of Human Genetics, 62:1212-1227, 1998.
160. Vincent, J.B.; Klempan, T.; Parikh, S.S.; Sasaki, T.; Meltzer, H.Y.; Sirugo, G.; Cola, P.; Petronis, A.; and Kennedy, J. Frequency analysis of large CAG/CTG trinucleotide repeats in schizophrenia and bipolar affective disorder. Molecular Psychiatry, 1:141-148, 1996.
161. Waddington, C.H. Principles of Embryology. London, England: George Allen & Unwin, 1956.
162. Walker, E., and Lewine, R.J. Prediction of adult-onset schizophrenia from childhood home movies of the patients. American Journal of Psychiatry, 147:1052-1056, 1990.
163. Wallace, M.R.; Andersen, L.B.; Saulino, A.M.; Gregory, P.E.; Glover, T.W.; and Collins, F.S. A de novo Alu insertion results in neurofibromatosis type 1. Nature, 353:864-866, 1991.
164. Walter, J.; Kruger, T.; Engemann, S.; Allen, N.D.; Kelsey, G.; Feil, R.; Forne, T.; and Reik, W. Genomic imprinting and modifier genes in the mouse. In: Russo, V.E.A.; Martienssen, R.A.; and Riggs, A.D., eds. Epigenetic Mechanisms of Gene Regulation. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1996. pp. 195-214.
165. Wang, Z.W.; Black, D.; Andreasen, N.C.; and Crowe, R.R. A linkage study of chromosome 11q in schizophrenia. Archives of General Psychiatry, 50:212-216, 1993.
166. Watanabe, S.; Kawai, J.; Hirotsune, S.; Suzuki, H.; Hirose, K.; Taga, C.; Ozawa, N.; Fushiki, S.; and Hayashizaki, Y. Accessibility to tissue-specific genes from methylation profiles of mouse brain genomic DNA. Electrophoresis, 16:218-226, 1995.
167. Weinberger, D.R. On the plausibility of "the neurodevelopmental hypothesis" of schizophrenia. Neuropsychopharmacology, 14(3S): 1-11, 1996.
168. Weinberger, D.R.; Berman, K.F.; Iadarola, M.; Driesen, N.; and Zee, R.F. Prefrontal cortical blood flow and cognitive function in Huntington's disease. Journal of Neurology, Neurosurgery and Psychiatry, 51:94-104, 1988.
169. Wilson, C.A.; Payton, M.N.; Elliott, G.S.; Buaas, F.W.; Cajulis, E.E.; Grosshans, D.; Ramos, L.; Reese, D.M.; Slamon, D.J.; and Calzone, F.J. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b. Oncogene, 14:1-16, 1997.
170. Wong, D.F.; Wagner, H.N., Jr.; Tune, L.E.; Dannals, R.F.; Pearlson, G.D.; Links, J.M.; Tamminga, C.A.; Broussolle, E.P.; Ravert, H.T.; Wilson, A.A.; Toung, J.K.T.; Malat, J.; Williams, F.A.; O'Touma, L.A.; Snyder, S.H.; Kuhar, M.J.; and Gjedde, A. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science, 234:1558-1563, 1986.
171. Woodcock, D.M.; Crowther, P.J.; Jefferson, S.; and Diver, W.P. Methylation of dinucleotides other than CpG: Implications for human maintenance methylation. Gene, 74:151-152, 1988.
172. Woolf, C.M. Does the genotype for schizophrenia often remain unexpressed because of canalization and stochastic events during development? Psychological Medicine, 27:659-668, 1997.
173. Yang, A.S.; Jones, P.A.; and Shibata, A. The mutational burden of 5-methylcytosine. In: Russo, V.E.A.; Martienssen, R.A.; and Riggs, A.D., eds. Epigenetic Mechanisms of Gene Regulation. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1996. pp. 77-94.
174. Yang, A.S.; Shen, J.C.; Zingg, J.M.; Mi, S.; and Jones, P.A. HhaI and HpaII DNA methyltransferases bind DNA mismatches, methylate uracil and block DNA repair. Nucleic Acids Research, 23:1380-1387, 1995.
175. Yeivin, A., and Razin, A. Gene methylation patterns and expression. In: Jost, J.P., and Saluz, H.P., eds. DNA Methylation: Molecular Biology and Biological Significance. Basel, Switzerland: Birkhauser Verlag, 1993. pp. 523-568.
176. Yolken, R.H., and Torrey, E.F. Viruses, schizophrenia and bipolar disorder. Clinical Microbiology Reviews, 8:131-145, 1995.
177. Zagris, N., and Podimatas, T. 5-Azacytidine changes gene expression and causes developmental arrest of early chick embryo. International Journal of Developmental Biology, 38:741-744, 1994.
178. Zigun, J., and Weinberger. D.R. In vivo studies of brain morphology in patients with schizophrenia. In: Lindenmayer, J.-P., and Kay, S.R., eds. New Biological Vistas on Schizophrenia. New York, NY: Brunner Mazel, 1992. pp. 57-81.
179. Zimonjic, D.B.; Popescu, N.D.; and DiPaolo, J.A. Chromosomal organization of viral integration sites in human papillomavirus-immortalized human keratinocyte cell lines. Cancer Genetics and Cytogenetics, 72:39-43, 1994.
180. Zou, S.; Ke, N.; Kim, J.M.; and Voytas, D.F. The Saccharomyces retrotransposon Ty5 integrates preferentially into regions of silent chromatin at the telomeres and mating loci. Genes and Development, 10:634-645, 1996.